Iron oxide nanoparticle-mediated hyperthermia stimulates dispersal in bacterial biofilms and enhances antibiotic efficacy
The dispersal phase that completes the biofilm lifecycle is of particular interest for its
potential to remove recalcitrant, antimicrobial tolerant biofilm infections. Here we found that …
potential to remove recalcitrant, antimicrobial tolerant biofilm infections. Here we found that …
Photodynamic and antibiotic therapy in combination to fight biofilms and resistant surface bacterial infections
F Barra, E Roscetto, AA Soriano, A Vollaro… - International journal of …, 2015 - mdpi.com
Although photodynamic therapy (PDT), a therapeutic approach that involves a
photosensitizer, light and O2, has been principally considered for the treatment of specific …
photosensitizer, light and O2, has been principally considered for the treatment of specific …
Successful treatment of biofilm infections using shock waves combined with antibiotic therapy
DP Gnanadhas, M Elango, S Janardhanraj… - Scientific reports, 2015 - nature.com
Many bacteria secrete a highly hydrated framework of extracellular polymer matrix on
suitable substrates and embed within the matrix to form a biofilm. Bacterial biofilms are …
suitable substrates and embed within the matrix to form a biofilm. Bacterial biofilms are …
Inhibition of type 1 fimbriae-mediated Escherichia coli adhesion and biofilm formation by trimeric cluster thiomannosides conjugated to diamond nanoparticles
Recent advances in nanotechnology have seen the development of a number of
microbiocidal and/or anti-adhesive nanoparticles displaying activity against biofilms. In this …
microbiocidal and/or anti-adhesive nanoparticles displaying activity against biofilms. In this …
In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains …
D Lebeaux, V Leflon-Guibout, JM Ghigo… - Journal of …, 2015 - academic.oup.com
Objectives Treatment of catheter-related bloodstream infections (CRBSI) is hampered by the
characteristic tolerance of bacterial biofilms towards antibiotics. Our objective was to study …
characteristic tolerance of bacterial biofilms towards antibiotics. Our objective was to study …
The effects of D-Tyrosine combined with amikacin on the biofilms of Pseudomonas aeruginosa
P She, L Chen, H Liu, Y Zou, Z Luo, A Koronfel… - Microbial …, 2015 - Elsevier
The biofilm formation of microorganisms causes persistent tissue infections resistant to
treatment with antimicrobial agents. Pseudomonas aeruginosa is commonly isolated from …
treatment with antimicrobial agents. Pseudomonas aeruginosa is commonly isolated from …
[HTML][HTML] Antimicrobial resistance in clinically important biofilms
F Rafii, ME Hart - World Journal of Pharmacology, 2015 - wjgnet.com
A biofilm contains a consortium of cohesive bacterial cells forming a complex structure that is
a sedentary, but dynamic, community. Biofilms adhere on biotic and abiotic surfaces …
a sedentary, but dynamic, community. Biofilms adhere on biotic and abiotic surfaces …
Kurzdarmsyndrom und Darmversagen–neue Entwicklungen
G Lamprecht - DMW-Deutsche Medizinische Wochenschrift, 2015 - thieme-connect.com
Das Darmversagen wird von den intestinalen Flüssigkeits-und Elektrolytverlusten sowie von
der ungenügenden Resorption von Makronährstoffen bestimmt und bedarf oft der individuell …
der ungenügenden Resorption von Makronährstoffen bestimmt und bedarf oft der individuell …
The role of contact-dependent growth inhibition toxin systems in bacterial competition and biofilm development
AD King - 2015 - etheses.whiterose.ac.uk
Contact-dependent growth inhibition (CDI) toxins are a recently identified family of
polymorphic toxins, initially found in Escherichia coli. CDI toxins are found widely spread in …
polymorphic toxins, initially found in Escherichia coli. CDI toxins are found widely spread in …
NOVEL MEMBRANE TARGETING ANTIMICROBIALS FOR DRUG-RESISTANT PATHOGENS
KOHJUN JIE - 2015 - scholarbank.nus.edu.sg
ANTIBIOTIC RESISTANCE IS A CRITICAL GLOBAL HEALTH CARE CRISIS, WHICH
REQUIRES URGENT ACTION TO DEVELOP MORE EFFECTIVE ANTIBIOTICS. THIS …
REQUIRES URGENT ACTION TO DEVELOP MORE EFFECTIVE ANTIBIOTICS. THIS …